Yanfeng Liu
9PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 24, 2025
Targeting KMT5C Suppresses Lung Cancer Progression and Enhances the Efficacy of Immunotherapy.Yunfeng Yuan, Qianyu Li, Guoquan Yan
|Nov 13, 2024
Post-translational toxin modification by lactate controls Staphylococcus aureus virulence.Yanan Wang, Yanfeng Liu, Guoxiu Xiang
|Jun 22, 2024
Protein O-fucosyltransferase 1 promotes PD-L1 stability to drive immune evasion and directs liver cancer to immunotherapy.Qianyu Li, Wenyun Guo, Yifei Qian
|Oct 17, 2023
KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression.Wenyun Guo, Songling Li, Yifei Qian
|Aug 09, 2023
Histone methyltransferase KMT5C drives liver cancer progression and directs therapeutic response to PARP inhibitors.Yu Tong, Fan Wang, Songling Li
|Nov 26, 2022
AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis.Yanan Wang, Mengjun Luo, Fan Wang
Pageof 2
